FDA NDC Directory · JSON-LD · Markdown

SOLIRIS

NDC 25682-001 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameECULIZUMAB
Labeler / ManufacturerAlexion Pharmaceuticals Inc.
Marketing categoryBiologic License Application · App BLA125166
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsECULIZUMAB (300 mg/30mL)
Marketing started20070402
Package count1

External sources

Source: openFDA. Public-domain (CC0).